On-body delivery systems for subcutaneous isatuximab could enable patient self-administration, according to Xavier Leleu, MD, PhD, improving convenience and transforming treatment for ...

The phase 3 IRAKLIA trial found that subcutaneous isatuximab delivered via an on-body system was as effective and safe as intravenous (IV) administration in relapsed/refractory multiple myeloma, ...

Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, ...

Explore the innovative subcutaneous delivery of isatuximab for multiple myeloma, enhancing patient experience and treatment ...

Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly ...

Multiple myeloma is currently an incurable blood cancer that affects a type of white blood cell called plasma cells, which are found in the bone marrow. 21, 22 In multiple myeloma, these malignant ...

Sustained MRD negativity (10-5) rates at 24 months or longer were more than doubled in transplant eligible patients treated with daratumumab-VRd vs VRd alone in the Phase 3 PERSEUS study1 Data ...

Shape: The nodules might be described as smooth, bumpy or spiculated (spikey). Behavior: This refers to how the nodule has changed (if prior scans are available) and may be described as unchanged, new ...

Cyber incidents affecting multiple Maine hospitals. Julia Simone and Ariana St Pierre, WGME. Mon, June 2nd 2025 at 12:00 PM. Updated Tue, June 3rd 2025 at 6:35 AM. 5. VIEW ALL PHOTOS.

Additionally, researchers reported a greater risk with a nodule that was part-solid in attenuation vs. solid or non-solid in attenuation (4.3% vs. 1.5% or 1.6%) and with a nodule that was more ...

Multiple law enforcement agencies responded on Sunday evening to shootings in the Harrisburg area of Augusta that resulted in two teens going to a hospital and multiple arrests. Following a report of ...

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus, multiple scientists and federal health ...